Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Net Margin Growth (3y) (2012 - 2026)

Analysis

Revvity (RVTY) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 191.00
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -482.00
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 1,264.00
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 3,776.00
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 209.00
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 184.00
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 22,769.00
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -998.00
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 3,064.00
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -1,588.00
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 209.00
Apr 5, 2026 -7,866.00
Dec 28, 2025 -1,802.00
Sep 28, 2025 -532.00
Jun 29, 2025 -1,252.00
Mar 30, 2025 -1,202.00
Dec 29, 2024 -1,677.00
Sep 29, 2024 -104.00
Jun 30, 2024 -1,827.00
Mar 31, 2024 -3,256.00
Oct 1, 2023 -1,691.00
Jul 2, 2023 -1,188.00
Apr 2, 2023 7,922.00
Jan 1, 2023 2,275.00
Oct 2, 2022 371.00
Jul 3, 2022 1,045.00
Apr 3, 2022 1,291.00
Jan 2, 2022 2,032.00
Oct 3, 2021 348.00
Jul 4, 2021 1,717.00